From diagnoses to treatment for both primary and specialty care, the patient and provider experience is undergoing a dramatic shift. Innovations and policies are repaving the patient journey. 2024 will see further advancements that embed new practices and paradigms.
What we’re watching
Beyond pills to durable, lasting treatment benefits
These new treatments are achieving commercial success, with multiple classes of newer modalities surpassing >$1 billion in annual sales per product.